Propanc Biopharma PPCB
NASDAQ PPCB
$0.32 -0.01 (-1.74%)
At close: Oct 21, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Return on Equity [ROE] (2012 - 2025)

Updated

Propanc Biopharma (PPCB) reported Return on Equity [ROE] of -161.86% for FY2026 (year ended Jun 30, 2026), up 1001.81 percentage points from -1163.67% in FY2025.

Analysis

Propanc Biopharma (PPCB) Return on Equity [ROE] (2012 - 2025) Analysis & Trends

  • According to Business Quant data, Return on Equity [ROE] came in at -1163.67% in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.32%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 7.21%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.52%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 21.39%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.75%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -18.38%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.97%
10 Propanc Biopharma 362,396.14 -1.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -532.52%
Sep 30, 2025 -448.62%
Jun 30, 2025 -368.29%
Mar 31, 2025 -792.48%
Jun 30, 2012 -2,006.89%
Mar 31, 2012 -307.71%
API Access

Propanc Biopharma Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PPCB&period=max&api_key=YOUR_API_KEY